FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

David Grimwade

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Procedures

Physiology

Concepts & Ideas

Treatment Outcome

Co-author Network

Publications

TOP 3
David Grimwade
The changing paradigm of prognostic factors in acute myeloid leukaemia.
Andrea Kühnl; David Grimwade
Molecular markers in acute myeloid leukaemia.
David Grimwade; Alan K Burnett
Getting to the heart of improving outcomes for patients with acute promyelocytic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of David Grimwade (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: David Grimwade
The changing paradigm of prognostic factors in acute myeloid leukaemia.
Best practice & research. Clinical haematology 2012;25(4):419-25.
2012: Andrea Kühnl; David Grimwade
Molecular markers in acute myeloid leukaemia.
International journal of hematology 2012;96(2):153-63.
2012: David Grimwade; Alan K Burnett
Getting to the heart of improving outcomes for patients with acute promyelocytic leukemia.
Oncology (Williston Park, N.Y.) 2012;26(7):647-9.
2011: Emanuele Ammatuna; Pau Montesinos; Syed Khizer Hasan; Safaa M Ramadan; Jordi Esteve; Maximillian Hubmann; Maria Pagoni; David Grimwade; Miguel Angel Sanz; Francesco Lo Coco
Presenting features and treatment outcome of acute promyelocytic leukemia arising after multiple sclerosis.
Haematologica 2011;96(4):621-5.
2011: Jelena V Jovanovic; Anne Lennard; Andrew J Peniket; Kristian Rennie; Paresh Vyas; Dominic Culligan; Justin Harrison; David Grimwade
Development of real-time quantitative polymerase chain reaction assays to track treatment response in retinoid resistant acute promyelocytic leukemia.
Frontiers in oncology 2011;1():35.
2011: M Joannides; A N Mays; A R Mistry; Neil Osheroff; A Reiter; Ellen Solomon; Joseph L Wiemels; F Lo Coco; C A Felix; Syed Khizer Hasan; David Grimwade
Molecular pathogenesis of secondary acute promyelocytic leukemia.
Mediterranean journal of hematology and infectious diseases 2011;3(1):e2011045.
2011: Salvatore Spicuglia; Guillaume Tibéri; Christelle Vincent-Fabert; Joaquin Zacarias-Cabeza; Touati Benoukraf; François Bertucci; Boris Calmels; Pierre Ferrier; David Grimwade; Ken Mills; AJ Saurin; Michael H Sieweke; E Duprez
Characterisation of genome-wide PLZF/RARA target genes.
PloS one 2011;6(9):e24176.
2010: Syed Khizer Hasan; Tiziana Ottone; Richard F Schlenk; Yuanyuan Xiao; Joseph L Wiemels; Maria Enza Mitra; Paolo Bernasconi; Francesco Di Raimondo; Maria Teresa Lupo Stanghellini; Pepa Marco; Ashley N Mays; Hartmut Döhner; Miguel A Sanz; Sergio Amadori; David Grimwade; Francesco Lo Coco
Analysis of t(15;17) chromosomal breakpoint sequences in therapy-related versus de novo acute promyelocytic leukemia: association of DNA breaks with specific DNA motifs at PML and RARA loci.
Genes, chromosomes & cancer 2010;49(8):726-32.
2010: David Grimwade; Robert K Hills; Anthony V Moorman; Helen Walker; Stephen Chatters; Anthony H Goldstone; Keith Wheatley; Christine J Harrison; Alan K Burnett
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
Blood 2010;116(3):354-65.
2010: Fiona Vaz; Helmut Hanenberg; Beatrice Schuster; Karen Barker; Constanze Wiek; Verena Erven; Kornelia Neveling; Daniela Endt; Ian Kesterton; Flavia Autore; Franca Fraternali; Marcel Freund; Linda Hartmann; David Grimwade; Roland Roberts; Heiner Schaal; Shehla Mohammed; Nazneen Rahman; Detlev Schindler; Christopher G Mathew
Mutation of the RAD51C gene in a Fanconi anemia-like disorder.
Nature genetics 2010;42(5):406-9.
2010: Ashley N Mays; Neil Osheroff; Yuanyuan Xiao; Joseph L Wiemels; Carolyn A Felix; Jo Ann W Byl; Kandeepan Saravanamuttu; Andrew Peniket; Robert Corser; Cherry Chang; Christine Hoyle; Anne Parker; Syed Khizer Hasan; Francesco Lo Coco; Ellen Solomon; David Grimwade
Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia.
Blood 2010;115(2):326-30.
2010: David Grimwade; Anita R Mistry; Ellen Solomon; Fabien Guidez
Acute promyelocytic leukemia: a paradigm for differentiation therapy.
Cancer treatment and research 2010;145():219-35.
2010: Melanie Joannides; David Grimwade
Molecular biology of therapy-related leukaemias.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2010;12(1):8-14.
2009: Miguel A Sanz; David Grimwade; Martin S Tallman; Bob Lowenberg; Pierre Fenaux; Elihu H Estey; Tomoki Naoe; Eva Lengfelder; Thomas Büchner; Hartmut Döhner; Alan K Burnett; Francesco Lo Coco
Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.
Blood 2009;113(9):1875-91.
2009: David Grimwade; Robert K Hills
Independent prognostic factors for AML outcome.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2009;():385-95.
2009: Nicola J M Brown; Michal Ramalho; Eva W Pedersen; Eva Moravcsik; Ellen Solomon; David Grimwade
PML nuclear bodies in the pathogenesis of acute promyelocytic leukemia: active players or innocent bystanders?
Frontiers in bioscience : a journal and virtual library 2009;14():1684-707.
2008: A Glasow; Angela Barrett; Kevin Petrie; Rajeev Gupta; Manuel Boix-Chornet; Da-Cheng Zhou; David Grimwade; Robert E Gallagher; Marieke von Lindern; Samuel Waxman; Tariq Enver; Guido Hildebrandt; Arthur Zelent
DNA methylation-independent loss of RARA gene expression in acute myeloid leukemia.
Blood 2008;111(4):2374-7.
2007: Fabien Guidez; Sarah Parks; Henna Wong; Jelena V Jovanovic; Ashley Mays; Amanda F Gilkes; Ken Mills; Marie-Claude Guillemin; Robin M Hobbs; Pier Paolo Pandolfi; Hugues de Thé; Ellen Solomon; David Grimwade
RARalpha-PLZF overcomes PLZF-mediated repression of CRABPI, contributing to retinoid resistance in t(11;17) acute promyelocytic leukemia.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(47):18694-9.
2007: Andreas Reiter; David Grimwade; Nicholas C P Cross
Diagnostic and therapeutic management of eosinophilia-associated chronic myeloproliferative disorders.
Haematologica 2007;92(9):1153-8.
2007: J Saldanha; Monique Silvy; N Beaufils; R Arlinghaus; G Barbany; Susan Branford; Jean-Michel Cayuela; Giovanni Cazzaniga; M Gonzalez; David Grimwade; V Kairisto; K Miyamura; M Lawler; Thomas Lion; Elizabeth Macintyre; F-X Mahon; Martin C Muller; M Ostergaard; Heike Pfeifer; Giuseppe Saglio; Charles L Sawyers; Orietta Spinelli; V H J van der Velden; J Q Wang; K Zoi; V Patel; P Phillips; P Matejtschuk; Jean Gabert
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: towards new standards for gene expression measurements.
Leukemia 2007;21(7):1481-7.
2007: Jelena V Jovanovic; Joannah Score; Katherine Waghorn; Daniela Cilloni; Enrico Gottardi; Georgia Metzgeroth; Philipp Erben; Helena Popp; Christoph Walz; Andreas Hochhaus; Catherine Roche-Lestienne; Claude Preudhomme; Ellen Solomon; Jane Apperley; Michela Rondoni; Emanuela Ottaviani; giovanni martinelli; Finella Brito-Babapulle; Giuseppe Saglio; Rüdiger Hehlmann; Nicholas C P Cross; Andreas Reiter; David Grimwade
Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia.
Blood 2007;109(11):4635-40.
2006: Elise Chapiro; Eric Delabesse; Vahid Asnafi; Corinne Millien; Frédéric Davi; Elizabeth Nugent; Kheira Beldjord; Torsten Haferlach; David Grimwade; Elizabeth Macintyre
Expression of T-lineage-affiliated transcripts and TCR rearrangements in acute promyelocytic leukemia: implications for the cellular target of t(15;17).
Blood 2006;108(10):3484-93.
2006: D W Milligan; David Grimwade; J O Cullis; L Bond; David M Swirsky; Charles Craddock; J Kell; J Homewood; Ken Campbell; S McGinley; Keith Wheatley; G Jackson
Guidelines on the management of acute myeloid leukaemia in adults.
British journal of haematology 2006;135(4):450-74.
2006: Susanne Saussele; K Adam; Andreas Hochhaus; marie bene; Thomas Büchner; A Burnett; G Finazzi; Christa Fonatsch; E Gluckman; Nicola Gökbuget; David Grimwade; Torsten Haferlach; M Hallek; Joerg Hasford; Dieter Hoelzer; P Ljungman; Dietger Niederwieser; Hubert Serve; B Simonsson; T J de Witte; Rüdiger Hehlmann
[Clinical research at the European LeukemiaNet].
Deutsche medizinische Wochenschrift (1946) 2006;131(43):2423-6.
2006: Nick Goulden; Paul Virgo; David Grimwade
Minimal residual disease directed therapy for childhood acute myeloid leukaemia: the time is now.
British journal of haematology 2006;134(3):273-82.
2006: Timothy Hughes; Michael W N Deininger; Andreas Hochhaus; Susan Branford; Jerald P Radich; Jaspal Kaeda; Michele Baccarani; Jorge Cortes; Nicholas C P Cross; Brian J Druker; Jean Gabert; David Grimwade; Rüdiger Hehlmann; Suzanne Kamel-Reid; Jeffrey H Lipton; Janina Longtine; giovanni martinelli; Giuseppe Saglio; Simona Soverini; Wendy Stock; John M Goldman
Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.
Blood 2006;108(1):28-37.
2005: Rosemary E Gale; Robert Hills; Arnold Pizzey; panos kottaridis; David M Swirsky; Amanda F Gilkes; Elizabeth Nugent; Ken Mills; Keith Wheatley; Ellen Solomon; Alan K Burnett; David C Linch; David Grimwade
Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promyelocytic leukemia.
Blood 2005;106(12):3768-76.
2005: Lucia Altucci; Aurélie Rossin; Oliver Hirsch; Angela Nebbioso; Dominique VITOUX; Emmanuelle Wilhelm; Fabien Guidez; Mariacarla De Simone; Ettore Mariano Schiavone; David Grimwade; Arthur Zelent; Hugues de Thé; Hinrich Gronemeyer
Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor.
Cancer research 2005;65(19):8754-65.
2005: Mary Frances McMullin; Elizabeth Nugent; A Thompson; Donald Hull; F G C Jones; David Grimwade
Prolonged molecular remission in PML-RARalpha-positive acute promyelocytic leukemia treated with minimal chemotherapy followed by maintenance including the histone deacetylase inhibitor sodium valproate.
Leukemia 2005;19(9):1676-7.
2005: Anita R Mistry; Carolyn A Felix; Ryan J Whitmarsh; Annabel Mason; Andreas Reiter; Bruno Cassinat; Anne Parry; Christoph Walz; Joseph L Wiemels; Mark Segal; Lionel Adès; Ian A Blair; Neil Osheroff; Andrew J Peniket; Marina Lafage-Pochitaloff; Nicholas C P Cross; Christine Chomienne; Ellen Solomon; Pierre Fenaux; David Grimwade
DNA topoisomerase II in therapy-related acute promyelocytic leukemia.
The New England journal of medicine 2005;352(15):1529-38.
2005: Charles Craddock; Sudhir Tauro; Paul Moss; David Grimwade
Biology and management of relapsed acute myeloid leukaemia.
British journal of haematology 2005;129(1):18-34.
2004: David Grimwade; Torsten Haferlach
Gene-expression profiling in acute myeloid leukemia.
The New England journal of medicine 2004;350(16):1676-8.
2004: Marc Tischkowitz; Neil V Morgan; David Grimwade; C Eddy; S Ball; I Vorechovsky; Stephen E Langabeer; Reinhard Stöger; Shirley V Hodgson; Christopher G Mathew
Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia.
Leukemia 2004;18(3):420-5.
2004: David Grimwade; T Enver
Acute promyelocytic leukemia: where does it stem from?
Leukemia 2004;18(3):375-84.
2004: Andreas Reiter; Eva Lengfelder; David Grimwade
Pathogenesis, diagnosis and monitoring of residual disease in acute promyelocytic leukaemia.
Acta haematologica 2004;112(1-2):55-67.
2004: David Grimwade; A Moorman; Robert Hills; Keith Wheatley; Helen Walker; G Harrison; Ch Harrison; Anthony Goldstone; Alan Burnett
Impact of karyotype on treatment outcome in acute myeloid leukemia.
Annals of hematology 2004;83 Suppl 1():S45-8.
2004: Rajinder Flora; David Grimwade
Real-time quantitative RT-PCR to detect fusion gene transcripts associated with AML.
Methods in molecular medicine 2004;91():151-73.
2003: Jean Gabert; Emmanuel Beillard; V H J van der Velden; W Bi; David Grimwade; N Pallisgaard; G Barbany; Giovanni Cazzaniga; Jean-Michel Cayuela; H Cavé; Fabrizio Pane; J L E Aerts; D De Micheli; Xavier Thirion; Vincent Pradel; M González; Susanne Viehmann; Maria Malec; Giuseppe Saglio; Jacques J M van Dongen
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
Leukemia 2003;17(12):2318-57.
2003: Anita R Mistry; Eva W Pedersen; Ellen Solomon; David Grimwade
The molecular pathogenesis of acute promyelocytic leukaemia: implications for the clinical management of the disease.
Blood reviews 2003;17(2):71-97.
2003: Alexander Thompson; Michael F Quinn; David Grimwade; Claire M O'Neill; Momin R Ahmed; Sean Grimes; Mary Frances McMullin; Finbarr Cotter; Terence R J Lappin
Global down-regulation of HOX gene expression in PML-RARalpha + acute promyelocytic leukemia identified by small-array real-time PCR.
Blood 2003;101(4):1558-65.
2003: Andreas Reiter; Susanne Saussele; David Grimwade; Joseph L Wiemels; Mark Segal; Marina Lafage-Pochitaloff; Christoph Walz; Andreas Weisser; Andreas Hochhaus; Andreas Willer; Anja Reichert; Thomas Büchner; Eva Lengfelder; Rüdiger Hehlmann; Nicholas C P Cross
Genomic anatomy of the specific reciprocal translocation t(15;17) in acute promyelocytic leukemia.
Genes, chromosomes & cancer 2003;36(2):175-88.
2002: David Grimwade; F Lo Coco
Acute promyelocytic leukemia: a model for the role of molecular diagnosis and residual disease monitoring in directing treatment approach in acute myeloid leukemia.
Leukemia 2002;16(10):1959-73.
2002: David Grimwade; Susan V Outram; Rajinder Flora; Stuart J Ings; Arnold Pizzey; Ricardo Morilla; Charles Craddock; David C Linch; Ellen Solomon
The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells.
Cancer research 2002;62(16):4730-5.
2002: John A Liu Yin; David Grimwade
Minimal residual disease evaluation in acute myeloid leukaemia.
Lancet 2002;360(9327):160-2.
2002: David Grimwade
Screening for core binding factor gene rearrangements in acute myeloid leukemia.
Leukemia 2002;16(5):964-9.
2002: David Grimwade
The significance of minimal residual disease in patients with t(15;17).
Best practice & research. Clinical haematology 2002;15(1):137-58.
2001: David Grimwade
The clinical significance of cytogenetic abnormalities in acute myeloid leukaemia.
Best practice & research. Clinical haematology 2001;14(3):497-529.
2001: David Grimwade; Helen Walker; G Harrison; FJ Oliver; Steve Chatters; Christine J Harrison; Keith Wheatley; Alan K Burnett; Anthony H Goldstone
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial.
Blood 2001;98(5):1312-20.
2001: Pascual Bolufer; Francesco Lo Coco; David Grimwade; Eva Barragán; Daniela Diverio; Bruno Cassinat; C Chomienne; Marcos Gonzalez; Dolors Colomer; M T Gomez; Isabel Marugan; José Román; M D Delgado; José García-Marco; Rafael Bornstein; J L Vizmanos; B Martinez; J Jansen; Ana Villegas; J M de Blas; Pablo Cabello; Miguel A Sanz
Variability in the levels of PML-RAR alpha fusion transcripts detected by the laboratories participating in an external quality control program using several reverse transcription polymerase chain reaction protocols.
Haematologica 2001;86(6):570-6.
2001: Susan V Outram; David Grimwade; Tessa Crompton
Repression of CD2 gene expression is mediated by an AP-2 related factor.
Biochemical and biophysical research communications 2001;281(2):409-15.
2001: H V New; Ahmet Dogan; K Patterson; David Grimwade
Testicular relapse in acute promyelocytic leukaemia.
British journal of haematology 2001;112(2):258.
2001: Stephen E Langabeer; JR Rogers; G Harrison; Keith Wheatley; Helen Walker; B J Bain; Alan K Burnett; Anthony H Goldstone; David C Linch; David Grimwade
EVI1 expression in acute myeloid leukaemia.
British journal of haematology 2001;112(1):208-11.
2000: David Grimwade; A Biondi; Marie-Joëlle Mozziconacci; A Hagemeijer; R Berger; M Neat; Kathy Howe; Nicole Dastugue; J Jansen; Isabelle Radford-Weiss; F Lo Coco; michel lessard; J M Hernandez; Eric Delabesse; D Head; V Liso; Danielle Sainty; Georges Flandrin; Ellen Solomon; Françoise Birg; Marina Lafage-Pochitaloff
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Groupe Français de Cytogénétique Hématologique, Groupe de Français d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies".
Blood 2000;96(4):1297-308.
2000: Danielle Sainty; V Liso; A Cantù-Rajnoldi; D Head; Marie-Joëlle Mozziconacci; Christine Arnoulet; Laurence Benattar; SUSANNA FENU; Marco Mancini; Eliane Duchayne; F X Mahon; N Gutierrez; Françoise Birg; Andrea Biondi; David Grimwade; Marina Lafage-Pochitaloff; Anne Hagemeijer; Georges Flandrin
A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.
Blood 2000;96(4):1287-96.
2000: David Grimwade; M Q Du; Stephen E Langabeer; J Rogers; Ellen Solomon
Screening for mutations of Bcl10 in leukaemia.
British journal of haematology 2000;109(3):611-5.
2000: S Iqbal; David Grimwade; A Chase; Anthony Goldstone; Alan Burnett; John M Goldman; David M Swirsky
Identification of PML/RARalpha rearrangements in suspected acute promyelocytic leukemia using fluorescence in situ hybridization of bone marrow smears: a comparison with cytogenetics and RT-PCR in MRC ATRA trial patients. MRC Adult Leukaemia Working Party.
Leukemia 2000;14(5):950-3.
1999: David Grimwade
The pathogenesis of acute promyelocytic leukaemia: evaluation of the role of molecular diagnosis and monitoring in the management of the disease.
British journal of haematology 1999;106(3):591-613.
1999: Alan K Burnett; David Grimwade; Ellen Solomon; Keith Wheatley; Anthony H Goldstone
Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.
Blood 1999;93(12):4131-43.
1999: S Allford; David Grimwade; Stephen E Langabeer; E Duprez; AJ Saurin; Steve Chatters; Helen Walker; P Roberts; J Rogers; B Bain; K Patterson; A McKernan; Paul S Freemont; Ellen Solomon; Alan Burnett; Anthony Goldstone; David C Linch
Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
British journal of haematology 1999;105(1):198-207.
1998: David Grimwade; R Jamal; N Goulden; Helena Kempski; S Mastrangelo; Paul Veys
Salvage of patients with acute promyelocytic leukaemia with residual disease following ABMT performed in second CR using all-trans retinoic acid.
British journal of haematology 1998;103(2):559-62.
1998: David Grimwade; Helen Walker; FJ Oliver; Keith Wheatley; C Harrison; G Harrison; J Rees; Ian Hann; R Stevens; Alan Burnett; Anthony Goldstone
The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.
Blood 1998;92(7):2322-33.
1998: M Hodges; C Tissot; Kathy Howe; David Grimwade; Paul S Freemont
Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies.
American journal of human genetics 1998;63(2):297-304.
1998: Stephen E Langabeer; David Grimwade; Helen Walker; JR Rogers; Alan K Burnett; Anthony H Goldstone; David C Linch
A study to determine whether trisomy 8, deleted 9q and trisomy 22 are markers of cryptic rearrangements of PML/RARalpha, AML1/ETO and CBFB/MYH11 respectively in acute myeloid leukaemia. MRC Adult Leukaemia Working Party. Medical Research Council.
British journal of haematology 1998;101(2):338-40.
1998: David Grimwade; Stephen E Langabeer; Kathy Howe; Ellen Solomon
RT-PCR in diagnosis and disease monitoring of acute promyelocytic leukemia (APL).
Methods in molecular biology (Clifton, N.J.) 1998;89():333-58.
1997: David Grimwade; Patricia Gorman; E Duprez; Kathy Howe; Stephen E Langabeer; FJ Oliver; Helen Walker; Dominic J Culligan; J Waters; M Pomfret; Anthony Goldstone; Alan Burnett; Paul S Freemont; Denise Sheer; Ellen Solomon
Characterization of cryptic rearrangements and variant translocations in acute promyelocytic leukemia.
Blood 1997;90(12):4876-85.
1997: David Grimwade; Helen Walker; FJ Oliver; Keith Wheatley; R Clack; A Burnett; Anthony Goldstone
What happens subsequently in AML when cytogenetic abnormalities persist at bone marrow harvest? Results of the 10th UK MRC AML trial. Medical Research Council Leukaemia Working Parties.
Bone marrow transplantation 1997;19(11):1117-23.
1997: D Rees; David Grimwade; Stephen E Langabeer; Alan Burnett; Anthony Goldstone
Influence of genetic predisposition to thrombosis on natural history of acute promyelocytic leukaemia. MRC Adult Leukaemia Working Party.
British journal of haematology 1997;96(3):490-2.
1997: David Grimwade; Ellen Solomon
Characterisation of the PML/RAR alpha rearrangement associated with t(15;17) acute promyelocytic leukaemia.
Current topics in microbiology and immunology 1997;220():81-112.
1996: David Grimwade; Kathy Howe; Stephen E Langabeer; L Davies; FJ Oliver; Helen Walker; D Swirsky; K Wheatley; Anthony Goldstone; Alan Burnett; Ellen Solomon
Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party.
British journal of haematology 1996;94(3):557-73.
1996: David Grimwade; Kathy Howe; Stephen E Langabeer; Alan Burnett; Anthony Goldstone; Ellen Solomon
Minimal residual disease detection in acute promyelocytic leukemia by reverse-transcriptase PCR: evaluation of PML-RAR alpha and RAR alpha-PML assessment in patients who ultimately relapse.
Leukemia 1996;10(1):61-6.
1994: David Grimwade; R Chopra; A King; P Shaw; Rachel Pearce; David C Linch; Anthony H Goldstone
Detection and significance of pulmonary Hodgkin's disease at autologous bone marrow transplantation.
Bone marrow transplantation 1994;13(2):173-9.